TY - JOUR
T1 - Neonatal ventral hippocampal lesions produce an elevation of ΔFosB-like protein(s) in the rodent neocortex
AU - Powell, Kelly J.
AU - Binder, Tammy L.
AU - Hori, Sarah
AU - Nakabeppu, Yusaku
AU - Weinberger, Daniel R.
AU - Lipska, Barbara K.
AU - Robertson, George S.
N1 - Funding Information:
This work was supported by a grant from the Ontario Mental Health Foundation. KJP was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research/Institute of Neurosciences, Mental Health and Addiction/Estate of Betty Irene West. TLB received support from the Associates in Psychiatry at the Ottawa General Hospital. GSR is supported by a CIHR-Rx&D Chair. We thank Zin Khaing and Ms Y Zhu for their excellent technical assistance.
PY - 2006/4
Y1 - 2006/4
N2 - Rats that have sustained bilateral excitotoxic lesions of the ventral hippocampus (VH) as neonates develop behavioral abnormalities as adults (hyper-responsiveness to stress, diminished prepulse inhibition, and increased sensitivity to dopamine agonists), which resemble certain aspects of schizophrenia. Although this behavioral profile is thought to reflect dysregulation of the mesolimbic dopamine system, the precise neuroanatomical and neurochemical substrates that mediate the emergence of these abnormalities during brain maturation are unclear. In order to identify putative sites responsible for the development of behavioral abnormalities following neonatal lesions of the VH, we utilized the chronic neuronal activity marker ΔFosB. By comparison to sham lesioned animals, bilateral destruction of the VH elevated ΔFosB expression throughout the caudate putamen and neocortex of animals lesioned as neonates. These increases were not observed in rats lesioned as young-adults, suggesting that ΔFosB induction in the cortex of neonatally lesioned rats may be related to altered cortical neurodevelopment. Accumulating evidence implicates ΔFosB in mediation of the long-lasting effects of altered dopaminergic neurotransmission on behavior. The present findings are consistent with this proposal and suggest that elevated expression of ΔFosB identifies overactive neurons that may contribute to the enhanced sensitivity to stress and dopaminergic agonists of rats that have sustained bilateral ventral hippocampal lesions as neonates.
AB - Rats that have sustained bilateral excitotoxic lesions of the ventral hippocampus (VH) as neonates develop behavioral abnormalities as adults (hyper-responsiveness to stress, diminished prepulse inhibition, and increased sensitivity to dopamine agonists), which resemble certain aspects of schizophrenia. Although this behavioral profile is thought to reflect dysregulation of the mesolimbic dopamine system, the precise neuroanatomical and neurochemical substrates that mediate the emergence of these abnormalities during brain maturation are unclear. In order to identify putative sites responsible for the development of behavioral abnormalities following neonatal lesions of the VH, we utilized the chronic neuronal activity marker ΔFosB. By comparison to sham lesioned animals, bilateral destruction of the VH elevated ΔFosB expression throughout the caudate putamen and neocortex of animals lesioned as neonates. These increases were not observed in rats lesioned as young-adults, suggesting that ΔFosB induction in the cortex of neonatally lesioned rats may be related to altered cortical neurodevelopment. Accumulating evidence implicates ΔFosB in mediation of the long-lasting effects of altered dopaminergic neurotransmission on behavior. The present findings are consistent with this proposal and suggest that elevated expression of ΔFosB identifies overactive neurons that may contribute to the enhanced sensitivity to stress and dopaminergic agonists of rats that have sustained bilateral ventral hippocampal lesions as neonates.
UR - http://www.scopus.com/inward/record.url?scp=33645037018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645037018&partnerID=8YFLogxK
U2 - 10.1038/sj.npp.1300883
DO - 10.1038/sj.npp.1300883
M3 - Article
C2 - 16132062
AN - SCOPUS:33645037018
SN - 0893-133X
VL - 31
SP - 700
EP - 711
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 4
ER -